Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
17.86
+0.47 (2.70%)
Nov 20, 2024, 4:00 PM EST - Market closed

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $62.90M in the quarter ending September 30, 2024, with 69.56% growth. This brings the company's revenue in the last twelve months to $203.45M, up 57.08% year-over-year. In the year 2023, Travere Therapeutics had annual revenue of $145.24M with 32.69% growth.

Revenue (ttm)
$203.45M
Revenue Growth
+57.08%
P/S Ratio
6.78
Revenue / Employee
$535,387
Employees
380
Market Cap
1.55B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023145.24M35.78M32.69%
Dec 31, 2022109.46M-22.38M-16.97%
Dec 31, 2021131.84M-66.48M-33.52%
Dec 31, 2020198.32M22.98M13.11%
Dec 31, 2019175.34M11.09M6.75%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.59B
InMode 423.75M
BioCryst Pharmaceuticals 412.58M
Kiniksa Pharmaceuticals International, 384.10M
Certara 372.80M
Dynavax Technologies 260.81M
Arvinas 161.10M
Intellia Therapeutics 43.09M
Revenue Rankings